VUMC in the news

MedPage Today deputy managing editor Ian Ingram interviewed Stacie Dusetzina, PhD, associate professor of Health Policy, for a story about her study on pharmaceutical industry dollars influencing prescribing habits for oncologists. Stat reporter Ed Silverman also interviewed her for a story about the study, and Reuters reporter Lisa Rapapport interviewed Dusetzina for a story about the study as well.
In addition, Rapaport interviewed Dusetzina for two more Reuters stories, one as an independent source for a story about a study that found insurance companies may be asking people to pay more money for drug co-payments than the drugs actually cost; and also as an independent source for a story about a study that found most Americans aren’t aware of cancer drug shortages that might lead some patients to receive less effective or more toxic treatments.
U.S. News & World Report reporter Stacey Colino interviewed Cosby Stone, MD, post-doctoral research fellow in Allergy/Immunology, for a story about why people can develop allergies as an adult if they never had them as a child.
Yahoo News reporter Korin Miller interviewed William Schaffner, MD, professor of Preventive Medicine, for a story about the difference between hepatitis A, B, C, D, and E.
The VUMC announcement of the creation of Nashville Biosciences has garnered several placements quoting Leeland Ekstrom, PhD, chief operating officer of Nashville Biosciences. These include Genetic Engineering & Biotechnology News – Clinicalomics, Healthcare Informatics, Becker’s Hospital Review, Venture Nashville, Clinical Trial Exchange, GenomeWeb, LifeScienceTN, Nashville Business Journal, BIO SmartBrief, Nashville Post, WPLN Nashville Public Radio, A.M.Best Company, Ask.com, BioNJ, Boston Business Journal, Ft. Worth Star-Telegram, Life Science Washington, Minneapolis Star-Tribune, WBTV Charlotte, Newsday.com and KCTV Kansas City.

